Exabis Library
Welcome to the e-CCO Library!
OP009: Long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn's disease: 52-week results of a phase III randomised controlled trial
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP009: Long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn’s Disease: 52-week results of a phase III randomised controlled trial
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:43 PM by ECCO Administrator
1
OP01 Higher vs. standard adalimumab maintenance regimens in patients with moderately to severely active ulcerative colitis: Results from the SERENE-UC maintenance study
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
OP010: Azathioprine dose reduction in patients with inflammatory bowel disease on combination therapy: a prospective study
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP010: Long term efficacy and safety of Ustekinumab for Crohn's disease: results from IM-UNITI long-term extension through 2 years
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP010: Long term efficacy and safety of Ustekinumab for Crohn’s Disease: Results from IM-UNITI long-term extension through 2 years
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:45 PM by ECCO Administrator
1
OP010: Shallow whole genome sequencing predicts the future cancer risk of low grade dysplastic lesions arising in Ulcerative Colitis
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1
OP010: Shallow whole-genome sequencing predicts the future cancer risk of low-grade dysplastic lesions arising in ulcerative colitis
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP011: Comparison of adalimumab monotherapy and a combination with azathioprine for patients with Crohn’s disease: a prospective, multicentre, open-labelled clinical trial (DIAMOND study)
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP011: Etrolizumab treatment leads to early improvement in symptoms and inflammatory biomarkers in anti-TNF-refractory patients in the open-label induction cohort of the phase 3 HICKORY study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP011: Integration of whole exome sequencing and RNA sequencing of intestinal biopsies in Inflammatory Bowel Disease identifies inflammation dependent effects
2018
ECCO'18 Vienna
Friday, 23 March 2018, 12:23 PM
1
OP011: Integration of whole-exome sequencing and RNA sequencing of intestinal biopsies in inflammatory bowel disease identifies inflammation-dependent effects
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP011:Etrolizumab treatment leads to early improvement in symptoms and inflammatory biomarkers in anti-TNF-refractory patients in the open-label induction cohort of the phase 3 HICKORY study
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:47 PM by ECCO Administrator
1
OP012: IL-23 is centrally involved in mediating molecular resistance to anti-TNF therapy in Crohn’s disease patients
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
OP012: Perioperative use of vedolizumab is not associated with short-term postoperative infectious complications in patients with Ulcerative Colitis undergoing (procto)colectomy with ileal pouch- anal anastomosis
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:49 PM by ECCO Administrator
1
OP012: Perioperative use of vedolizumab is not associated with short-term postoperative infectious complications in patients with ulcerative colitis undergoing (procto)colectomy with ileal pouch-anal anastomosis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP012: Risk factors for colorectal neoplasia in ulcerative colitis: results from the largest and longest-running colonoscopic surveillance programme
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM
OP013: Disease management and outcomes of patients with Crohn's disease at high risk of recurrence. Results from PRACTICROHN study
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
OP013: Disease management and outcomes of patients with Crohn’s Disease at high risk of recurrence. Results from PRACTICROHN study
2017
ECCO'17 Barcelona
Wednesday, 15 March 2017, 2:52 PM by ECCO Administrator
1
OP013: Evolution of corticosteroid use in Crohn’s disease patients between 1991 and 2014: results from the Dutch population-based Inflammatory Bowel Disease South Limburg cohort
2016
ECCO '16 Amsterdam
Friday, 22 February 2019, 9:49 AM